Cross-omics strategies and personalised options for lung cancer immunotherapy.

🤖 Plain-English Summary

Lung cancer is one of the most common malignant tumours worldwide and its high mortality rate makes it a leading cause of cancer-related deaths. By integrating multi-omics, we have gained a more comprehensive understanding of the process of lung cancer development and progression, and discovered potential immunotherapy targets.

🔑 Key Findings

• To address this daunting challenge, we need a comprehensive understanding of the pathogenesis and progression of lung cancer in order to adopt more effective therapeutic strategies.
• In this regard, integrating multi-omics data of the lung provides a highly promising avenue.
• Multi-omics approaches such as genomics, transcriptomics, proteomics, and metabolomics have become key tools in the study of lung cancer.

🔗 Related Resources